20 January 2021
A « Nanobiosensor » enabling quantification of kinase activity in tumor Xenografts in vivo (Small 2021)
A scientist from the “Kinase Biosensors & Inhibitors” of the Cellular Pharmacology team of IBMM, in collaboration with researchers from I2TC, Strasbourg and from IAB, Grenoble have just (...)